BAF60a interacts with p53 to recruit the SWI/SNF complex

J Biol Chem. 2008 May 2;283(18):11924-34. doi: 10.1074/jbc.M705401200. Epub 2008 Feb 26.

Abstract

To understand the tumor-suppressing mechanism of the SWI/SNF chromatin remodeling complex, we investigated its molecular relationship with p53. Using the pREP4-luc episomal reporter, we first demonstrated that p53 utilizes the chromatin remodeling activity of the SWI/SNF complex to initiate transcription from the chromatin-structured promoter. Among the components of the SWI/SNF complex, we identified BAF60a as a mediator of the interaction with p53 by the yeast two-hybrid assay. p53 directly interacted only with BAF60a, but not with other components of the SWI/SNF complex, such as BRG1, SRG3, SNF5, or BAF57. We found out that multiple residues at the amino acid 108-150 region of BAF60a were involved in the interaction with the tetramerization domain of p53. The N-terminal fragment of BAF60a containing the p53-interacting region as well as small interfering RNA for baf60a inhibited the SWI/SNF complex-mediated transcriptional activity of p53. The uncoupling of p53 with the SWI/SNF complex resulted in the repression of both p53-dependent apoptosis and cell cycle arrest by the regulation of target genes. These results suggest that the SWI/SNF chromatin remodeling complex is involved in the suppression of tumors by the interaction with p53.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Apoptosis / drug effects
  • Cell Cycle / drug effects
  • Cell Line
  • Chromatin Assembly and Disassembly / drug effects
  • Chromosomal Proteins, Non-Histone / chemistry
  • Chromosomal Proteins, Non-Histone / genetics
  • Chromosomal Proteins, Non-Histone / metabolism*
  • Down-Regulation / drug effects
  • Doxorubicin / pharmacology
  • Humans
  • Mice
  • Mutant Proteins / metabolism
  • Protein Binding / drug effects
  • Protein Interaction Mapping
  • Protein Structure, Tertiary
  • Transcription Factors / metabolism*
  • Transcription, Genetic / drug effects
  • Transduction, Genetic
  • Tumor Suppressor Protein p53 / chemistry
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Chromosomal Proteins, Non-Histone
  • Mutant Proteins
  • SWI-SNF-B chromatin-remodeling complex
  • Smarcd1 protein, mouse
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Doxorubicin